Having established the YAP/TBX5/FGFR1 axis in AR-negative PCa cell lines, we next determined whether cabozantinib treatment could elicit an increase in FGFR1 expression in AR-positive PCa cell lines. Here, FGFR1 is linked to posterior cortical atrophy.